申请人:Grünenthal GmbH
公开号:US20160151337A1
公开(公告)日:2016-06-02
The invention relates to substituted bicyclic pyrroloheterocyclyl compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.
本发明涉及用于ICRAC抑制剂的取代双环吡咯杂环基化合物,以及含有这些化合物的制药组合物和这些化合物用于治疗和/或预防疾病和/或疾病,特别是炎症性疾病和/或炎症性疾病的用途。